Updated results of a phase Ib/II randomised study: Polatuzumab vedotin (Pola) plus bendamustine (B) and rituximab (R) in relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) Meeting Abstract
| Authors: | Sehn, L. H.; McMillan, A.; Matasar, M. J.; Flowers, C. R.; Kamdar, M.; Hertzberg, M.; Assouline, S.; Kim, T. M.; Kim, W. S.; Ozcan, M.; Croft, B.; Herrera, A. F.; Hirata, J.; Cheng, J.; Ku, G. |
| Abstract Title: | Updated results of a phase Ib/II randomised study: Polatuzumab vedotin (Pola) plus bendamustine (B) and rituximab (R) in relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) |
| Meeting Title: | 60th Annual Scientific Meeting of the British Society for Haematology (BSH) |
| Journal Title: | British Journal of Haematology |
| Volume: | 189 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Apr 27-29 |
| Meeting Location: | Birmingham, UK |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2020-04-01 |
| Start Page: | 93 |
| End Page: | 94 |
| Language: | English |
| ACCESSION: | WOS:000528597400129 |
| PROVIDER: | wos |
| PUBMED: | 32337705 |
| DOI: | 10.1111/bjh.16638 |
| Notes: | Meeting cancelled due to COVID-19 pandemic -- Meeting Abstract: BSH2020-PO-081 -- Source: Wos |
